Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TAK-676 |
Trade Name | |
Synonyms | TAK 676|TAK676|Dazostinag disodium |
Drug Descriptions |
TAK-676 is a STING agonist, which activates the STING pathway in immune cells, potentially leading to increased antitumor immune response (Ann Oncol 35 (2024): S678-S679; NCI Drug Dictionary). |
DrugClasses | STING1 Agonist 19 |
CAS Registry Number | 2553413-93-5 |
NCIT ID | C173377 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + TAK-676 | Pembrolizumab TAK-676 | 0 | 2 |
TAK-676 | TAK-676 | 0 | 1 |